Federal workplace testing proposals
Published November 4, 2026 · Coverage October 25–31, 2026, Pacific · Lower priority
On October 29, HHS proposed separate revisions to its mandatory guidelines for federal workplace drug-testing programs using oral fluid and urine. Comments on both proposals are due December 28, 2026. These are proposals for the identified federal programs; the notices do not by themselves create a universal private-hospital testing duty. Specific changes and affected organizations require separate review.
Applicability and suggested action: Federal-program employers and participating laboratories can compare the two proposals with the testing programs they actually administer and decide whether to comment by December 28. Do not apply them as a general hospital mandate.
Complete edition and supplemental material
This article in the complete report →
Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.
Read the entire Compliance Sweep report →